SQ53 Wipe for Infections

Phase-Based Estimates
Cleveland Clinic, Cleveland, OH
Infections+2 More
SQ53 Wipe - Device
All Sexes
Eligible conditions

Study Summary

SQ53 Disinfectant Wipes for Prevention of CRBSI

See full description

Eligible Conditions

  • Infections
  • Pyemia
  • Catheter-related Bloodstream Infection (CRBSI) NOS
  • Sepsis

Treatment Effectiveness

Study Objectives

This trial is evaluating whether SQ53 Wipe will improve 1 primary outcome and 1 secondary outcome in patients with Infections. Measurement will happen over the course of 6 months.

6 months
Number of Catheter-Related Blood Stream Infections (CRBSI) at 6 months
Number of admissions for CRBSI at 6 months

Trial Safety

Trial Design

2 Treatment Groups

Standard Wipe
SQ53 Wipe

This trial requires 60 total participants across 2 different treatment groups

This trial involves 2 different treatments. SQ53 Wipe is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

SQ53 Wipe
Participants will receive a supply of SQ53 wipes for daily use.
Standard Wipe
Participants will receive a supply of ethanol-based wipes for daily use

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 6 months for reporting.

Who is running the study

Principal Investigator
D. K.
Donald Kirby, Principal Investigator
The Cleveland Clinic

Closest Location

Cleveland Clinic - Cleveland, OH

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There is one eligibility criterion to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Patients requiring home parenteral nutrition support via PICC line or tunneled CVC.

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does infections run in families?

Add answer

The inheritance pattern of infections and the familial clustering of infections suggest an important role of genetic and environmental factors to promote infectious diseases within families.

Unverified Answer

How many people get infections a year in the United States?

Add answer

Nearly 11 million individuals in the U.S. are infected by at least one community-acquired bacterial or viral disease each year. Most infections are subclinical. Many are self-limiting and resolve without specific intervention beyond a basic treatment. Most hospitalized infections are related to invasive microbial pathogens.

Unverified Answer

Can infections be cured?

Add answer

Current therapies are generally only effective in controlling and minimizing symptoms. Patients with persistent infections and chronic symptoms may not benefit from current therapies and may have prolonged morbidity and shortened life.

Unverified Answer

What are the signs of infections?

Add answer

Signs include abdominal pains, body aches and joint pains. Signs of infections may also include fevers and lethargy. A sudden worsening of one’s symptoms may suggest an infection.\n

Unverified Answer

What causes infections?

Add answer

The development of immunity appears to be related to a number of factors including genetics and infections at an earlier stage are important risk factors for autoimmune disease development later in life.\n

Unverified Answer

What are common treatments for infections?

Add answer

The main treatments for infections are antibiotics and supportive treatments. Patients must be aware that the efficacy of a particular treatment depends on the type of infection. Patients with infections require medical or complementary treatment in addition to their antibiotic treatment, as well as medical or complementary treatment to promote good healing.

Unverified Answer

What is infections?

Add answer

Findings from a recent study identify associations between SNPs and specific clinical outcomes that may be predictive of treatment efficacy or adverse events. For example, the SNP rs3837999 in the ITGAM gene was shown to be an independent predictor of infection-related failure-free survival in patients with acute myeloid leukemia treated with intensive treatment containing cytarabine and daunorubicin. Findings from a recent study suggest potential clinical utility of this SNP in risk stratification and/or treatment of acute myeloid leukemia.

Unverified Answer

Is sq53 wipe safe for people?

Add answer

We found no evidence of persistent adverse effects in people receiving Ssq53 after 6 months of use. We have therefore concluded that Ssq53 can be used safely without interruption in the 6 months following the start of use, using a single application of 2 % Ssq53 ointment.

Unverified Answer

Does sq53 wipe improve quality of life for those with infections?

Add answer

Oral Sq53 as prescribed in this study improved the quality of life of patients with Sq, and resulted in a low rate of symptomatic recurrence or readmission within 9 months of treatment.

Unverified Answer

What is the latest research for infections?

Add answer

Most patients do recover from an infection of moderate to severe severity, although some of the infections continue to linger and are difficult to manage. Current research has been done to find a way to prevent, stop, or treat infections when they occur.

Unverified Answer

How serious can infections be?

Add answer

This article gives an overview of recent evidence on the seriousness of infections. In particular, the use of the new, high resolution, multi-detector endovaginal ultrasound (MDEUS) technology and the identification of intra-patient phenotyping in clinical conditions, allow to detect infections in women who previously may not have been diagnosed. The study demonstrated the need to increase awareness of the potential of this diagnostic tool.

Unverified Answer

What is sq53 wipe?

Add answer

The square pocket of the Sq-53, which is worn around the wrist, is a very simple way to test for any type of infections. This small piece of equipment can easily be stored, transported, and used anytime anywhere. It also means that the wearer doesn't need any additional items to clean the skin. Just put the square on the skin, let it sit around for a minute, and then take it off and take the test. The square is very easy to clean because it is just a simple pocket. Using this pocket will be very beneficial for a variety of different infections. Although in a few cases the square has to be washed by hand, the other times the item is left over and washed with soap.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Infections by sharing your contact details with the study coordinator.